February 10, 2023
The weekend ended with a bang as Abbott and Globus Medical both announced significant deals. Abbott picked up publicly traded Cardiovascular Solutions for $890...
00:48:45
January 20, 2023
In this week’s episode, CEO Kevin Sayer takes a few minutes to share Dexcom’s vision for the future OUTSIDE of diabetes. What does this...
01:15:18
June 17, 2022
In this episode, Michael Matson, analyst at Needham, explains his thoughts behind a possible J&J acquisition of Boston Scientific. He also explains why he...
01:19:27